GLULP2: A Potential Drug Target and Biomarker for Glutamine Synthesis

Target Name: GLULP2

NCBI ID: G2754

GLULP2

Other Name(s): Glutamate-ammonia ligase (glutamine synthetase)-like 2 | GLULL2 | Glutamate-ammonia ligase (glutamine synthase)-like 2G | Glutamate-ammonia ligase (glutamine synthetase) pseudogene 2 | Glutamate-ammonia ligase pseudogene 2 | glutamate-ammonia ligase pseudogene 2

GLULP2: A Potential Drug Target and Biomarker for Glutamine Synthesis

Glutamine synthetase (GS) is a critical enzyme in the pathway of glutamine synthesis, which is a crucial nutrient for the growth and maintenance of muscle, nerve, and other tissues. Mutations in the GS gene have been linked to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Therefore, the study of GS and its related molecular mechanisms, including GLULP2, has become an important field in modern biology.

GLULP2, also known as Glutamate-ammonia ligase (GAL) 2, is a protein that plays a crucial role in the regulation of glutamine synthesis. It is a 23-kDa protein that is expressed in various tissues and cells, including muscle, nerve, and cancer cells. GLULP2 functions as a negative regulator of GS, which means that it inhibits the activity of GS.

The GLULP2 gene is located on chromosome 16 at position 16.2 and has 21 open reading frames (ORFs). GLULP2 is composed of a catalytic domain and a non-catalytic domain. The catalytic domain is responsible for the binding of nutrients, such as glutamate and ammonia, to the active site of GLULP2, where they can participate in the formation of the final product, glutamyl-Co-A. The non-catalytic domain is involved in the regulation of GLULP2 activity.

GLULP2 is a key regulator of glutamine synthesis, as it controls the amount of glutamine produced by GS. Glutamine is a vital nutrient for the growth and maintenance of muscle, nerve, and other tissues. It is a small molecule that has various functions, including the regulation of cell signaling, DNA replication, and stress resistance. The availability of glutamine is critical for the maintenance of cellular homeostasis and for the regulation of various cellular processes.

Studies have shown that GLULP2 plays a crucial role in the regulation of glutamine synthesis. By using techniques such as site-directed mutagenesis and biochemical assays, researchers have found that GLULP2 is involved in the regulation of GS activity. Mutation in the GLULP2 gene has been linked to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Therefore, the study of GLULP2 is becoming increasingly important for the development of new therapeutic strategies for these diseases.

In addition to its role in regulating GS activity, GLULP2 has also been shown to play a role in the regulation of other cellular processes. For example, GLULP2 has been shown to be involved in the regulation of cell signaling, as it has been shown to interact with various signaling molecules, including TGF-β, NF-kappa-B, and MAPK. GLULP2 has also been shown to be involved in the regulation of DNA replication, as it has been shown to play a role in the repair of DNA damage.

GLULP2 has also been shown to have potential as a drug target. The inhibition of GLULP2 activity has been shown to have various therapeutic effects, including the inhibition of cancer cell growth, the inhibition of neurodegenerative disorders, and the inhibition of autoimmune diseases. Therefore, GLULP2 is an attractive target for the development of new therapeutic strategies for various diseases.

In conclusion, GLULP2 is a protein that plays a crucial role in the regulation of glutamine synthesis. Its function as a negative regulator of GS and its involvement in various cellular processes make it an attractive target for the development of new therapeutic strategies for various diseases. Further research is needed to fully understand the role of GLULP2 in the regulation of glutamine synthesis and its potential as a drug target.

Protein Name: Glutamate-ammonia Ligase Pseudogene 2

The "GLULP2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLULP2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets